
Sign up to save your podcasts
Or


Editor Niall Boyce talks with Michael Schonenberg about his trial of neurofeedback as a therapy for patients with attention-deficit hyperactivity disorder.
By The Lancet PsychiatryEditor Niall Boyce talks with Michael Schonenberg about his trial of neurofeedback as a therapy for patients with attention-deficit hyperactivity disorder.